Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Medizinische Klinik (Munich, Germany : 1983)|March 15, 1990
[A registry of medullary thyroid cancer in West Germany]F Raue, M Späth-Röger, J Winter, et al.
Scandinavian Journal of Rheumatology. Supplement|October 12, 2000
Efficacy and tolerability of tropisetron in primary fibromyalgia--a highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study GroupL Färber, T Stratz, W Brückle, et al.
International Journal of Clinical Pharmacology Research|November 16, 2001
Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patientsL Färber, T H Stratz, W Brückle, et al.
Schmerz (Berlin, Germany)|July 5, 2012
[Etiology and pathophysiology of fibromyalgia syndrome]C Sommer, W Häuser, M Burgmer, et al.
European Journal of Pain (London, England)|August 28, 2015
Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?P Marchettini, S Wilhelm, H Petto, et al.
Medical Microbiology and Immunology|November 12, 2022
Variable detection of Omicron-BA.1 and -BA.2 by SARS-CoV-2 rapid antigen testsAndreas Osterman, Irina Badell, Christopher Dächert, et al.
Medical Microbiology and Immunology|August 10, 2023
Ten rapid antigen tests for SARS-CoV-2 widely differ in their ability to detect Omicron-BA.4 and -BA.5Franziska Krenn, Christopher Dächert, Irina Badell, et al.
Medical Microbiology and Immunology|February 21, 2022
Impaired detection of omicron by SARS-CoV-2 rapid antigen testsAndreas Osterman, Irina Badell, Elif Basara, et al.
Medical Microbiology and Immunology|August 10, 2023
Automated antigen assays display a high heterogeneity for the detection of SARS-CoV-2 variants of concern, including several Omicron sublineagesAndreas Osterman, Franziska Krenn, Maximilian Iglhaut, et al.
Annals of the Rheumatic Diseases|July 24, 2007
EULAR evidence-based recommendations for the management of fibromyalgia syndromeS F Carville, L Arendt-Nielsen, S Arendt-Nielsen, et al.
Pageof 7